Sukik, AyahAlalwani, JoudGanji, Vijay2024-12-042024-12-042023-01Sukik, A., Alalwani, J., & Ganji, V. (2023). Vitamin D, Gut Microbiota, and Cardiometabolic Diseases-A Possible Three-Way Axis. International Journal of Molecular Sciences, 24(2), 940. https://doi.org/10.3390/ijms24020940https://hdl.handle.net/1805/44761Metabolic syndrome (MetSyn) is a precursor for several cardiometabolic diseases such as obesity, type-2 diabetes mellitus (T2DM), and cardiovascular diseases. Emerging evidence suggests that vitamin D deficiency links to cardiometabolic diseases through microbiota. A combination of poor vitamin D status and dysbiosis may contribute to the progression of cardiometabolic diseases. Therefore, in this review, we present the relationship among vitamin D, microbiota, and cardiometabolic diseases with a focus on MetSyn. We searched major databases for reports on vitamin D, microbiota, and MetSyn until June 2022. We reviewed 13 reports on the relation between vitamin D and MetSyn (6 randomized controlled and 7 cross-sectional studies) and 6 reports on the effect of vitamin D on the gut microbiome. Adequate vitamin D status has a beneficial effect on gut microbiota, therefore preventing the progression of MetSyn. Further, well-controlled studies are needed for a better understanding of the mechanisms of action involving vitamin D and microbiota in the pathogenesis of cardiometabolic diseases.enAttribution 4.0 International25-hydroxyvitamin Ddiabetesgut microbiomeArticle